Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

PROKIDNEY CORP. (PROK)

$1.41 -1.40% NASDAQ: PROK · 15-min delayed
  • WINSTON-SALEM, North Carolina
  • Public · NASDAQ: PROK
  • 231 employees
$307.8MMarket cap
-$69.0MNet income
231Employees
PROKNASDAQ
2022IPO

About PROKIDNEY CORP.

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Net income
-$69.0M
Total assets
$335.6M
Market cap
$307.8M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: PROK
$1.41 -1.40%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$1.33 $3.30

52-week range

Market cap
$307.8M
Shares outstanding
218.3M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Jul 12, 2022

Prokidney Corp. (PROK) Stock Price

  • Reported a net loss of $69.0M.
  • Trading 57% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review PROKIDNEY CORP..

Write a review
Newsroom

News about PROKIDNEY CORP.

News & sentiment via Polygon.io

FAQ

Prokidney Corp.: frequently asked questions

Is Prokidney Corp. an American company?

Prokidney Corp. is a US-based company headquartered in Winston-Salem, North Carolina, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Prokidney Corp. headquartered?

Prokidney Corp. is headquartered in Winston-Salem, North Carolina, United States.

Is Prokidney Corp. publicly traded?

Yes — Prokidney Corp. is a publicly traded company. Its stock trades under the ticker symbol PROK on the NASDAQ.

What does Prokidney Corp. do?

Prokidney Corp. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →